Respiratory Syncytial Virus Vaccines – Talk Bio

Actionable Insights Powered by AI

Impact of New CDC Guidelines on RSV Vaccine Makers

9 months ago talkbio0Tagged Centers for Disease Control and Prevention (U.S.), Guidelines, Guillain-Barre Syndrome, Maker (occupation), Moderna, Pfizer, Recommendation, Respiratory Syncytial Virus Vaccines, SmithKline Beecham, Vaccination, Vaccines

RSV vaccine, CDC guidelines, vaccine makers, Moderna, Pfizer, GSK, Guillain-Barré syndrome, vaccination recommendations

CDC Expands RSV Vaccine Recommendations for Adults 75 and Older

10 months ago talkbio0Tagged Adult, Centers for Disease Control and Prevention (U.S.), older, public health medicine (field), Recommendation, Respiratory Syncytial Virus Vaccines, Vaccination

RSV vaccine, CDC, adults 75 and older, vaccination recommendations, public health

FDA Expands Approval of GSK’s RSV Vaccine to Include At-Risk Adults Aged 50-59

11 months ago talkbio0Tagged Adult, Approved, Arexvy, At-Risk, Respiratory syncytial virus, Respiratory Syncytial Virus Vaccines, SmithKline Beecham, United States Food and Drug Administration

RSV vaccine, GSK, FDA approval, at-risk adults, respiratory syncytial virus, Arexvy